The autoinflammatory hypothesis of AD suggests chronic immune dysfunction contributes to neuronal damage, making immune modulation a promising therapeutic strategy
Clinical studies show significant reductions in cardiovascular risk, with some medications reducing major adverse cardiovascular events by up to 20%
The data suggests that, when used appropriately and combined with the right support, oral semaglutide may offer a highly effective alternative
Sermorelin has been the default growth hormone peptide for two decades
Backed by Clinical Research Glycine and Recovery Helps reduce oxidative stress (important during weight loss) Improves deep sleep (where growth hormone and tissue repair occur) Supports collagen production great for joints, skin, and recovery after workouts Glycine and Muscle Health Preserves muscle in states of inflammation, calorie restriction, and aging Boosts protein synthesis through the mTOR pathway Reduces muscle-wasting signals and increases antioxidant defense This matters because semaglutide can reduce appetite so much that patients under-eat, risking muscle loss